ADM, Syngenta settle lawsuit over biotech
corn exports to China
Send a link to a friend
[February 17, 2018]
By Tom Polansek
CHICAGO (Reuters) - U.S. grain merchant
Archer Daniels Midland Co has settled a lawsuit with Syngenta over the
seed company's launch of a biotech corn strain that roiled grain exports
to China, according to regulatory documents filed on Friday.
ADM sued Syngenta four years ago for selling the corn variety known as
Agrisure Viptera or MIR 162 before it was approved for import by China,
an importer on U.S. grain. China rejected U.S. corn cargoes that
contained the unauthorized strain, which caused financial losses for
ADM, according to the lawsuit.
China ultimately approved imports of Viptera corn in 2014.
ADM and Syngenta reached a confidential settlement over the matter in
December, according to an annual report the grain handler filed with the
U.S. Securities and Exchange Commission.
Cargill Inc [CARG.UL], another major grain handler, and U.S. farmers
also sued Syngenta. Last year, Syngenta, now owned by ChemChina
[CNNCC.UL], agreed to settle farmers' lawsuits for close to $1.5
billion.
The Cargill case is set for trial in September, according to Syngenta.
[to top of second column]
|
A Syngenta logo is pictured in its office in Singapore, February 12,
2016. REUTERS/Edgar Su/File Photo
"Syngenta is continuing to defend against the claims of other
exporters, and continues to believe that American farmers should
have access to the latest U.S.-approved technologies to help them
increase their productivity and crop yield," spokesman Paul Minehart
said in an email.
Growers also sued ADM over the matter, claiming the company was
negligent in failing to screen for biotech corn. China's rejections
of U.S. shipments caused corn prices to plummet, according the
farmers' lawyers. ADM remains a defendant in court actions in
Illinois, which the company has sought to dismiss, the SEC filing
said.
(Reporting by Tom Polansek; editing by Diane Craft)
[© 2018 Thomson Reuters. All rights
reserved.]
Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |